Search Videos and More
Video
Complex Patient Case Review for Oncologic and Benign Urology
The Fox Chase–Temple Urologic Institute delivers expert care for both complex oncologic and benign urologic conditions. Backed by a team of renowned urologic specialists, we are recognized regionally and internationally for offering innovative, leading-edge treatments.
News
Fox Chase Cancer Center Fellow Dr. Joseph Van Galen Awarded American Society of Clinical Oncology Young Investigator Award
Joseph Van Galen, MD, MS, Chief Fellow in the Hematology/Oncology Fellowship Program at Fox Chase Cancer Center
News
Married People May Have Better Colorectal Cancer Outcomes, Fox Chase Cancer Center Study Shows
Namrata Vijayvergia, MD, Assistant Chief of Gastrointestinal Medical Oncology at Fox Chase Cancer Center
News
Electronic Health Record Intervention Boosts Fertility Preservation for Young Cancer Patients at Fox Chase Cancer Center
Christopher Cann, MD, Director of the Young Adult Cancer Program and Assistant Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center
News
New Fox Chase Cancer Center Study Shows Partially Absorbable Mesh Significantly Lowers Parastomal Hernia Risk Following Bladder Removal
Parastomal hernia is a common complication among patients who undergo bladder removal and ileal conduit urinary diversion. Now, a new study “Very Low Rate of Parastomal Hernia Using Partially Absorbable Macroporous Mesh for Prophylactic Reinforcement in Ileal Conduit Urinary Diversion: A Collaborative Approach Between Urology and Plastic/Reconstructive Surgery,” presented by Fox Chase Cancer Center clinicians at the American Urological Association’s (AUA) 2025 Annual Meeting supports the use of partially absorbable synthetic, non-biologic parastomal mesh to significantly reduce this risk in real-world practice.
News
Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds
Results from a study presented by Fox Chase Cancer Center researchers at the Society of Surgical Oncology 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.
News
Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer
Removing and testing at least 18 lymph nodes during surgery was associated with more accurate staging and better survival rates for colon cancer patients, according to research presented today at the Society of Surgical Oncology 2025 Annual Meeting. The findings from researchers at Fox Chase Cancer Center challenge the current standard of care for staging colon cancer, which calls for removal and examination of 12 lymph nodes.
News
INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy
Alexander Kutikov, MD, FACS, and Matthew R. Zibelman, MD, are conducting a new trial called INSITE to attempt to answer that question.
News
ASCO Genitourinary Cancer Symposium 2025: Fox Chase Advances Cancer Prevention, Research, and Potential Cures
This year, Fox Chase faculty and Fellows presented research that revealed tangible benefits for genitourinary cancer patient outcomes and quality of life.
News
A Video Is Worth a Thousand Words in Preparing Patients for Melanoma Surgery
News
A tragic death becomes a life force.
“A defining moment in my life was when my father was diagnosed with glioblastoma. At the time, we lived in New York’s Hudson Valley, and no area medical center offered treatment for a serious and complicated diagnosis like his. The only available therapy was in Manhattan, so at age 16, with just a learner’s permit, I drove my dad into the city to fight for his life while I maneuvered the George Washington Bridge as a novice driver,” says James P. Nitzkorski, MD, FACS, FSSO, a former Surgical Oncology Fellow at Fox Chase Cancer Center, and now, a surgical oncologist at Nuvance Health and Program Director for the General Surgery Residency at Vassar Brothers Medical Center, both in Poughkeepsie, NY. His father’s experience p
News
Plan Before a Treatment Road Ends
The First FDA-Approved Gene Therapy for Metastatic Synovial Sarcoma